JPH09224658A - Production of both jc virus particle and coat protein of jc virus - Google Patents

Production of both jc virus particle and coat protein of jc virus

Info

Publication number
JPH09224658A
JPH09224658A JP8062167A JP6216796A JPH09224658A JP H09224658 A JPH09224658 A JP H09224658A JP 8062167 A JP8062167 A JP 8062167A JP 6216796 A JP6216796 A JP 6216796A JP H09224658 A JPH09224658 A JP H09224658A
Authority
JP
Japan
Prior art keywords
region
virus
dna fragment
producing
expression vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8062167A
Other languages
Japanese (ja)
Inventor
Kazuo Nagashima
和郎 長嶋
Kotaro Yasui
孝太郎 保井
Yukiko Shishido
由紀子 宍戸
Naoto Kagiyama
直人 鍵山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aisin Corp
Original Assignee
Aisin Seiki Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aisin Seiki Co Ltd filed Critical Aisin Seiki Co Ltd
Priority to JP8062167A priority Critical patent/JPH09224658A/en
Publication of JPH09224658A publication Critical patent/JPH09224658A/en
Pending legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PROBLEM TO BE SOLVED: To produce both a JC virus particle and a coat protein of the JC virus in a high yield and in a short time. SOLUTION: A DNA fragment containing a genetic region of a late protein of a JC virus is prepared and an agnoprotein region arranged between the 277th and the 492nd positions counted from the origin of replication to the downstream side in the genetic region of the late protein of the JC virus is then deleted therefrom to prepare a DNA fragment capable of producing a virus particle. Further, the prepared DNA fragment capable of producing the virus particle is integrated into an expression vector and the resultant expression vector is transduced into a host cell to produce the JC virus particle. The DNA fragment capable of producing the virus particle is preferably a VP231 region DNA fragment containing a VP231 region in the genetic region of the late protein. Each region of the VP23, VP1 and VP3 arranged in the VP231 region is capable of producing a coat protein of the JC virus.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【技術分野】本発明は,例えば,進行性多巣性白質脳症
を引き起こすJCウイルス粒子の製造方法,及びJCウ
イルス外郭蛋白の製造方法に関する。
TECHNICAL FIELD The present invention relates to, for example, a method for producing JC virus particles that cause progressive multifocal leukoencephalopathy, and a method for producing a JC virus outer protein.

【0002】[0002]

【従来技術】ウイルスは,蛋白質によって形成された粒
子の中にその遺伝子を保有しており,独自の遺伝子を宿
主細胞のオルガネラを利用して発現する。そのため,ウ
イルスは遺伝子導入のための担体として用いられてい
る。また,臨床分野においては,遺伝子治療を目的とし
たウイルスベクターの開発も行われ,その安全性と有用
性の検討が進められている。
2. Description of the Related Art A virus has its gene in a particle formed by a protein and expresses its own gene by utilizing the organelle of a host cell. Therefore, the virus is used as a carrier for gene transfer. In the clinical field, viral vectors have been developed for gene therapy, and their safety and usefulness are being investigated.

【0003】かかるウイルス研究が行われている中,J
Cウイルスは特にその研究,開発が要求されている。即
ち,JCウイルスは,稀に進行性多巣性白質脳症(Progr
essive Multifocal Leukoencephalopathy; 以下PML
という。)を引き起こす。JCウイルスは,世界人口の
約7割がその抗体を有していることから分かるように,
全世界に蔓延しているウイルスである。またJCウイル
スは,高い神経向性を示し,ヒト脳のオリゴデンドログ
リアに特異的に感染しその核内に局在する。また,JC
ウイルスは,ポリオーマウイルス属に属し,SV40等
と同様,感染細胞の核内で脱核しその遺伝子を放出する
と考えられている。
While such virus research is being conducted, J
The C virus is particularly required to be researched and developed. That is, the JC virus rarely causes progressive multifocal leukoencephalopathy (Progr
essive Multifocal Leukoencephalopathy; PML
That. )cause. As can be seen from the fact that about 70% of the JC virus has its antibody,
It is a virus that has spread all over the world. The JC virus shows high neurotropicity, specifically infects oligodendroglia of the human brain, and is localized in the nucleus. Also, JC
The virus belongs to the genus Polyomavirus and is considered to release the gene by enucleating in the nucleus of the infected cell like SV40 and the like.

【0004】[0004]

【解決しようとする課題】しかしながら,上記研究に供
するための,JCウイルスの培養は非常に困難で,その
培養可能な細胞系も限られていた(Padgett らの方法:
Lancet, I, 1267-1260, 1971) 。また,短時間で高力価
のウイルスを得ることができないため,その研究は遅れ
ていた。また,PMLの発症機序についても不明な点が
多い。また,数々の遺伝性神経疾患についてもその遺伝
子レベルでの発症機序が明らかにされたが,その治療へ
の試みは未だなされていない。
[Problems to be Solved] However, it is very difficult to culture the JC virus for use in the above research, and the cell lines in which it can be cultured have been limited (Padgett et al.
Lancet, I, 1267-1260, 1971). Also, the study was delayed because high titer virus could not be obtained in a short time. Moreover, there are many unclear points about the pathogenic mechanism of PML. In addition, the pathogenic mechanism of a number of hereditary neurological diseases at the gene level has been clarified, but no attempt has been made to treat it.

【0005】本発明はかかる従来の問題点に鑑み,JC
ウイルス粒子又はJCウイルス外郭蛋白を,高い収率で
短時間で産生することができる,JCウイルス粒子又は
JCウイルス外郭蛋白の製造方法を提供しようとするも
のである。
In view of such conventional problems, the present invention provides a JC
An object of the present invention is to provide a method for producing a JC virus particle or a JC virus envelope protein, which can produce a virus particle or a JC virus envelope protein in a high yield in a short time.

【0006】[0006]

【課題の解決手段】請求項1に記載の発明は,図1〜図
4に示すJCウイルスの後期蛋白遺伝子領域を含むDN
A断片を調製し,次いで,上記DNA断片から,上記後
期蛋白遺伝子領域の内,複製開始点から下流側に数えて
第277〜第492番の間に配列したagnoprot
ein領域を欠失させて,ウイルス粒子産生性DNA断
片を作成し,次いで,上記ウイルス粒子産生性DNA断
片を発現ベクターに組み込み,次いで,該発現ベクター
を宿主細胞に導入してJCウイルス粒子を産生させるこ
とを特徴とするJCウイルス粒子の製造方法である。
The invention according to claim 1 is a DN containing the late protein gene region of the JC virus shown in FIGS. 1 to 4.
A fragment was prepared, and then, from the above DNA fragment, the agnoprot sequenced between the 277th to the 492nd positions in the late protein gene region, counted from the replication origin to the downstream side.
Ein region is deleted to prepare a virus particle-producing DNA fragment, then the above virus particle-producing DNA fragment is incorporated into an expression vector, and then the expression vector is introduced into a host cell to produce JC virus particles. A method for producing JC virus particles, which comprises:

【0007】本発明において最も注目すべきことは,上
記後期蛋白遺伝子領域の内,agnoprotein領
域を欠失させることにある。上記agnoprotei
n領域を欠失させたウイルス粒子産生性DNA断片を発
現ベクターに組み込み,その後,宿主細胞に導入し,宿
主細胞を増殖することによって,JCウイルス粒子を,
高収率で短時間で産生することができる。
What is most noticeable in the present invention is to delete the agnoprotein region of the above-mentioned late protein gene region. The above agnoprotei
A virus particle-producing DNA fragment lacking the n region is incorporated into an expression vector, and then introduced into a host cell, and the host cell is propagated to obtain a JC virus particle.
It can be produced in high yield in a short time.

【0008】上記の製造方法により得られるJCウイル
ス粒子は,JCウイルスの構成蛋白の集合体であり,特
にCOS7細胞に感染する性質を有する。そのため,J
Cウイルス粒子はJCウイルスを解析する上で,有用な
研究材料となる。
The JC virus particles obtained by the above-mentioned production method are an assembly of constituent proteins of JC virus and have the property of infecting COS7 cells in particular. Therefore, J
The C virus particle is a useful research material in analyzing the JC virus.

【0009】次に,上記後期蛋白遺伝子領域を含むDN
A断片は,請求項2に記載のように,複製開始点から下
流側に数えて第883〜第2533番の間に存在する塩
基配列が,図5〜図7に示す塩基配列からなることが好
ましい。これにより,更に高い収率でJCウイルス粒子
を製造することができる。尚,図1〜図7に示す番号
は,JCウイルスの複数開始点から下流側に配列する塩
基数を意味する。
Next, a DN containing the above-mentioned late protein gene region
As described in claim 2, in the A fragment, the nucleotide sequence existing between the 883rd to the 2533rd number counted from the replication origin to the downstream side may consist of the nucleotide sequences shown in FIGS. 5 to 7. preferable. As a result, JC virus particles can be produced with a higher yield. It should be noted that the numbers shown in FIGS. 1 to 7 mean the number of bases arranged downstream from the multiple initiation points of the JC virus.

【0010】次に,上記ウイルス粒子産生性DNA断片
は,JCウイルスの後期蛋白遺伝子領域DNAからag
noprotein領域を欠失させたDNA断片であ
る。このウイルス粒子産生性DNA断片は,請求項3に
記載のように,複製開始点から下流側に数えて第526
〜第2533番の間に配列するVP231領域を含むこ
とが好ましい。これにより,更に,JCウイルス粒子の
収率を,最大限に高めることができる。
Next, the above virus particle-producing DNA fragment is agglated from the JC virus late protein gene region DNA.
It is a DNA fragment in which the noprotein region has been deleted. This viral particle-producing DNA fragment is, as described in claim 3, counted from the replication origin to the downstream side at the 526th position.
It is preferable to include a VP231 region arranged between # 2 and # 2533. This can further maximize the yield of JC virus particles.

【0011】上記後期蛋白遺伝子領域DNAは,図1〜
図4に示すごとく,agnoprotein領域遺伝子
と,3つのウイルス外郭蛋白遺伝子とを有する。agn
oprotein領域遺伝子は,JCウイルスのDNA
の複製開始点から下流側に数えて第277〜第492番
に位置し,その塩基配列は図1,図8に示すとおりであ
る。
The above-mentioned late protein gene region DNA is shown in FIG.
As shown in FIG. 4, it has an agnoprotein region gene and three viral envelope protein genes. agn
The oprotein region gene is the DNA of JC virus.
It is located at the 277th to 492nd positions counting from the replication origin of the DNA, and its base sequence is as shown in FIGS. 1 and 8.

【0012】また,上記3つウイルスの外郭蛋白遺伝子
は,VP1,VP23及びVP3の3領域を有する。こ
れらの3領域は,上記VP231領域に含まれ,それぞ
れJCウイルス外郭蛋白を構成する蛋白を産生する機能
を果たす。VP1領域は,複製開始点から下流側に数え
て第1469〜第2533番目までの間に位置し,その
塩基配列は図3,図4,図9〜図13に示すとおりであ
る。VP23領域は,複製開始点から下流側に数えて第
526〜第1560番に位置し,その塩基配列は図1〜
図3に示すとおりである。
The outer protein genes of the three viruses have three regions, VP1, VP23 and VP3. These three regions are included in the VP231 region, and each has a function of producing a protein constituting a JC virus outer coat protein. The VP1 region is located between the 1469th and the 2533rd positions counted from the replication origin to the downstream side, and its nucleotide sequence is as shown in FIGS. 3, 4, and 9 to 13. The VP23 region is located at the 526th to 1560th positions counting downstream from the replication origin, and its nucleotide sequence is shown in FIG.
As shown in FIG.

【0013】VP3領域は,複製開始点から下流側に数
えて第883〜第1560番に位置し,その塩基配列は
図2,図3,図14〜図16に示すとおりである。VP
3領域は,VP23領域の塩基配列の一部と重複してい
る。尚,図8〜図16において,上段は塩基配列を,下
段は上段の塩基配列に対応したアミノ酸配列を示す。
The VP3 region is located from the replication origin to the downstream side from the 883rd to the 1560th position, and its nucleotide sequence is as shown in FIGS. 2, 3 and 14 to 16. VP
The 3 region overlaps with a part of the base sequence of the VP23 region. 8 to 16, the upper row shows the base sequence and the lower row shows the amino acid sequence corresponding to the upper base sequence.

【0014】上記JCウイルスとしては,例えば,JC
ウイルスTokyo−1株を用いる。このJCウイルス
Tokyo−1株は,本邦で初めてPML患者の剖検脳
より,発明者らによって分離,精製されて,JCウイル
ス遺伝子がクローニングされたものである。JCウイル
スの分離,精製は,例えばPadgettらの方法(La
ncet,I,1267-1260, 1971) により行うことができる。
Examples of the JC virus include JC virus.
The virus Tokyo-1 strain is used. This JC virus Tokyo-1 strain is the first cloned JC virus gene in Japan after being isolated and purified by the inventors from an autopsy brain of a PML patient. The JC virus can be isolated and purified by, for example, the method of Padgett et al. (La
ncet, I, 1267-1260, 1971).

【0015】JCウイルスTokyo−1株の上記後期
蛋白遺伝子領域DNAを増幅させる方法としては,クロ
ーニングベクターを用いる方法がある。即ち,上記後期
蛋白遺伝子領域DNAをクローニングベクターに挿入結
合する。クローニングベクターとしては,取扱いの容易
さから,大腸菌を宿主とするベクタープラスミドが好ま
しい。ベクタープラスミドとしては,例えば,pUC1
3,pUC18,pUC19又はpBR322由来のも
のを用いることができる。
As a method for amplifying the above-mentioned late protein gene region DNA of JC virus Tokyo-1 strain, there is a method using a cloning vector. That is, the above-mentioned late protein gene region DNA is inserted and ligated into a cloning vector. As a cloning vector, a vector plasmid using Escherichia coli as a host is preferable because it is easy to handle. As the vector plasmid, for example, pUC1
Those derived from 3, pUC18, pUC19 or pBR322 can be used.

【0016】ベクタープラスミドとしてpUC19を用
いた場合には,以下の方法により上記後期蛋白遺伝子領
域DNAを挿入結合したクローニングベクターを選択す
ることが好ましい。即ち,上記後期蛋白遺伝子領域DN
Aを挿入結合したpUC19を,42℃の温度で大腸菌
DH5aに導入し,トリプトファン,イーストエキスト
ラクト,NaCl,アンピシリン,寒天を含む培地(以
下,LB−Agar寒天培地という。)に,イソプロピ
ルチオ─D−ガラクトシド(以下,IPTGという。)
と5─ブロモ─4─クロロ─3─インドリル─b−D─
ガラクトシド(以下,X─galという。)とを加え,
培養する。
When pUC19 is used as the vector plasmid, it is preferable to select a cloning vector into which the above-mentioned late protein gene region DNA has been inserted and bound by the following method. That is, the above-mentioned late protein gene region DN
PUC19 having A-inserted thereinto was introduced into Escherichia coli DH5a at a temperature of 42 ° C., and isopropylthio-D was added to a medium containing tryptophan, yeast extract, NaCl, ampicillin and agar (hereinafter referred to as LB-Agar agar medium). -Galactoside (hereinafter referred to as IPTG)
And 5-bromo-4-chloro-3-indolyl-b-D-
Add galactoside (hereinafter referred to as X-gal),
Incubate.

【0017】pUC19は,アンピシリン耐性遺伝子及
びb−D−ガラクトシダーゼ(以下,lacZとい
う。)遺伝子を保有している。外来遺伝子であるJCウ
イルスのDNA断片は,pUC19のlacZ遺伝子領
域に挿入されるので,組み換えpUC19ではlacZ
が発現されず,基質であるX−galとの呈色反応をお
こさない。そのため,組み換えpUC19,即ち後期蛋
白遺伝子領域DNAを組み込んだクローニングベクター
を有する大腸菌形質転換株を,容易に選択することがで
きる。
PUC19 has an ampicillin resistance gene and a b-D-galactosidase (hereinafter referred to as lacZ) gene. Since the foreign gene JC virus DNA fragment is inserted into the lacZ gene region of pUC19, it is lacZ in recombinant pUC19.
Is not expressed and does not cause a color reaction with the substrate X-gal. Therefore, recombinant pUC19, that is, an Escherichia coli transformant having a cloning vector incorporating the late protein gene region DNA can be easily selected.

【0018】上記クローニングベクターに組み込まれた
JCウイルスの遺伝子をコードする上記後期蛋白遺伝子
領域DNAは,発現ベクターに組み込む。発現ベクター
としては,例えば,図20に示すごとく,武部ら(Take
be st al., Molecular and Cellular Biology, vol. 8,
466-472, 1988) の方法に基づいて作成した発現ベクタ
ーがある。
The late protein gene region DNA encoding the JC virus gene incorporated into the cloning vector is incorporated into an expression vector. As an expression vector, for example, as shown in FIG. 20, Takebe et al.
be st al., Molecular and Cellular Biology, vol. 8,
466-472, 1988).

【0019】上記発現ベクターは宿主細胞に導入する。
上記宿主細胞としては,特に制限はないが,サル腎細胞
由来のCOS7細胞を用いることが最も好ましい。その
理由は,JCウイルスがヒト脳由来であるため,ヒトと
同じ霊長類由来細胞での発現に適しているからである。
The expression vector is introduced into a host cell.
The host cell is not particularly limited, but monkey kidney cell-derived COS7 cells are most preferably used. The reason is that since the JC virus is derived from human brain, it is suitable for expression in the same primate-derived cells as human.

【0020】上記発現ベクターの宿主細胞への導入法と
しては,例えば,ハナハン(Hanahan)法,リポ
フェクチン法,リン酸カルシウム法によるトランスフェ
クション,マイクロインジェクション,又はエレクトロ
ポレーション等の方法がある。以上の方法により,JC
ウイルス粒子を高収率で容易に短時間で発現することが
できる。
As a method for introducing the expression vector into a host cell, there are, for example, a Hanahan method, a lipofectin method, a transfection by the calcium phosphate method, microinjection, electroporation and the like. By the above method, JC
Viral particles can be easily expressed in high yield in a short time.

【0021】次に,JCウイルス外郭蛋白の製造方法と
しては,例えば,請求項4に記載のように,図1〜図4
に示すJCウイルスの後期蛋白遺伝子領域を含むDNA
断片を調製し,次いで,上記後期蛋白遺伝子領域の内,
複製開始点から下流側に数えて第526〜第1560番
の間に配列するVP23領域を含むVP23領域DNA
断片と,複製開始点から下流側に数えて第1469〜第
2533番の間に配列するVP1を含むVP1領域DN
A断片と,複製開始点から下流側に数えて第883〜第
1560番の間に配列するVP3領域を含むVP3領域
DNA断片とを調製し,次いで,上記VP23領域DN
A断片と上記VP1領域DNA断片と上記VP3領域D
NA断片とをそれぞれ発現ベクターに組み込み,次い
で,上記VP23領域DNA断片を組み込んだ発現ベク
ターと,上記VP1領域DNA断片を組み込んだ発現ベ
クターと,上記VP3領域DNA断片を組み込んだ発現
ベクターとを,宿主細胞に導入してJCウイルス外郭蛋
白を産生させることを特徴とするJCウイルス外郭蛋白
の製造方法がある。
Next, as a method for producing the JC virus outer coat protein, for example, as shown in claim 4, as shown in FIGS.
DNA containing the late protein gene region of JC virus shown in
A fragment is prepared and then, in the late protein gene region,
VP23 region DNA containing the VP23 region arranged between the 526th to 1560th positions counting downstream from the replication origin
A fragment and a VP1 region DN including VP1 arranged between the 1469th and 2533rd positions counted downstream from the replication origin
A fragment and a VP3 region DNA fragment containing the VP3 region located between the 883rd and 1560th positions counted downstream from the origin of replication were prepared, and then the VP23 region DN was prepared.
A fragment, the VP1 region DNA fragment, and the VP3 region D
Each of the NA fragment and the VP23 region DNA fragment was inserted into an expression vector, and then the VP1 region DNA fragment was inserted into the expression vector, and the VP3 region DNA fragment was inserted into the expression vector. There is a method for producing a JC virus envelope protein, which comprises introducing it into cells to produce the JC virus envelope protein.

【0022】上記VP23領域,VP1領域,及びVP
3領域は,JCウイルス外郭蛋白を産生する遺伝子であ
る。従って,これらの3種類の領域をそれぞれ含むVP
23領域DNA断片,VP1領域DNA断片,及びVP
3領域DNA断片を調製し,これらDNA断片を,それ
ぞれ別個に発現ベクターに組み込み,宿主細胞に導入
し,増殖させることにより,JCウイルス外郭蛋白を,
高い収率で効率よく製造することができる。
VP23 area, VP1 area, and VP
Region 3 is a gene that produces the JC virus coat protein. Therefore, a VP containing each of these three types of areas
23 region DNA fragment, VP1 region DNA fragment, and VP
By preparing a three-region DNA fragment, individually incorporating these DNA fragments into an expression vector, introducing into a host cell, and proliferating, the JC virus outer peripheral protein
It can be efficiently produced with a high yield.

【0023】上記の製造方法により得られるJCウイル
ス外郭蛋白は,検出に必要な抗JCウイルス抗体を作成
する抗原となるなど,JCウイルスを解析する上で,有
用な研究材料となる。
The JC virus outer coat protein obtained by the above-mentioned production method becomes a useful research material for analyzing JC virus, such as an antigen for producing an anti-JC virus antibody necessary for detection.

【0024】上記VP23領域,VP1領域,及びVP
3領域の各DNA断片は,それぞれクローニングベクタ
ーに挿入し,該クローニングベクターを細胞系に導入し
増殖させることにより,増幅した後,上記発現ベクター
に組み込むことが好ましい。これにより,更に効率良く
大量のJCウイルス外郭蛋白を産生することができる。
また,上記の各DNA断片は,サブクローニングによっ
ても,増幅することができる。
VP23 area, VP1 area, and VP
It is preferable that each DNA fragment in the three regions is inserted into a cloning vector, amplified by introducing the cloning vector into a cell line and proliferating, and then incorporated into the expression vector. As a result, a large amount of JC virus envelope protein can be produced more efficiently.
Each of the above DNA fragments can also be amplified by subcloning.

【0025】また,上記VP23領域,VP1領域,及
びVP3領域の各DNA断片は,例えば,上記後期蛋白
遺伝子領域DNAを制限酵素により切断することにより
調製することができる。JCウイルスの後期蛋白遺伝子
領域DNAに適当な制限酵素認識部位がない場合には,
制限酵素認識配列を有するプライマーを用いたPCR法
にて増幅した遺伝子産物を挿入断片として利用すればよ
い。
The DNA fragments of the VP23 region, VP1 region, and VP3 region can be prepared, for example, by cutting the above-mentioned late protein gene region DNA with a restriction enzyme. When there is no suitable restriction enzyme recognition site in the late protein gene region DNA of JC virus,
A gene product amplified by PCR using a primer having a restriction enzyme recognition sequence may be used as an insert fragment.

【0026】上記JCウイルス粒子の製造方法及びJC
ウイルス外郭蛋白の製造方法は,遅発性ウイルス感染症
であるPMLの診断や,その他JCウイルスのウイルス
学的基礎研究に有用であるばかりでなく,Krebbe
病,異染性白質変成症,Pelizaeus−Merz
basher病等の先天性代謝異常による神経疾患の遺
伝子治療において行われる遺伝子操作材料をも提供す
る。以下,実施形態例を示して本発明を更に詳細に具体
的に説明するが,本発明は以下の実施形態例に限定され
るものではない。
Method for producing the above JC virus particles and JC
The method for producing the viral envelope protein is not only useful for the diagnosis of PML, which is a late viral infection, and for the basic virological research of other JC viruses, but it is also useful for Krebbe.
Disease, metachromatic leukodystrophy, Pelizaeus-Merz
It also provides a genetically engineered material used in gene therapy for neurological diseases caused by inborn errors of metabolism such as Basher disease. Hereinafter, the present invention will be described in more detail with reference to embodiments, but the present invention is not limited to the following embodiments.

【0027】[0027]

【発明の実施の形態】本発明の実施形態例に係る,JC
ウイルス粒子及びJCウイルス外郭蛋白の製造方法につ
いて,図1〜図22を用いて説明する。本例の製造方法
の概要を説明すると,図17,図18に示すごとく,ま
ず,JCウイルスの後期蛋白遺伝子領域DNAを取得
し,次いで,後期蛋白遺伝子領域DNAの一部を切断し
て,agnoprotein,VP231,VP1,V
P23及びVP3の各種領域DNA断片を取得し,これ
らを適宜組み合わせて発現ベクターに組み込み,その後
宿主細胞に導入する。
BEST MODE FOR CARRYING OUT THE INVENTION JC according to an embodiment of the present invention
The method for producing virus particles and JC virus outer coat protein will be described with reference to FIGS. The outline of the production method of this example will be described. As shown in FIGS. 17 and 18, first, the late protein gene region DNA of the JC virus is obtained, and then a part of the late protein gene region DNA is cleaved to carry out the agnoprotein. , VP231, VP1, V
DNA fragments of various regions of P23 and VP3 are obtained, appropriately combined and incorporated into an expression vector, and then introduced into a host cell.

【0028】以下,上記のJCウイルス粒子の製造方法
について,図17のS81〜S88,図18のS91〜
S98の各ステップを示しながら,詳細に説明する。
Hereinafter, regarding the method for producing the above-mentioned JC virus particles, S81 to S88 of FIG. 17 and S91 to S91 of FIG.
A detailed description will be given while showing each step of S98.

【0029】(後期蛋白遺伝子領域DNAの取得)ま
ず,図17に示すごとく,JCウイルスTokyo−1
株をPML患者の剖検脳より分離した(S81)。次い
で,分離したJCウイルスを初代ヒト胎児脳細胞を用い
て継代した(S82)。次いで,上記JCウイルスから
DNAを取り出し,精製した(S83)。
(Acquisition of Late Protein Gene Region DNA) First, as shown in FIG. 17, JC virus Tokyo-1.
The strain was isolated from the autopsy brain of a PML patient (S81). Then, the separated JC virus was passaged using primary human fetal brain cells (S82). Then, DNA was extracted from the JC virus and purified (S83).

【0030】次いで,JCウイルスのDNAを,制限酵
素EcoRIで切断した(S84)。次に,上記切断D
NA断片を,プラスミドベクターpUC13のEcoR
I部位に挿入結合した(S85)。
Next, the JC virus DNA was cleaved with the restriction enzyme EcoRI (S84). Next, the cutting D
The NA fragment was transformed into EcoR of the plasmid vector pUC13.
It was inserted and bound to the I site (S85).

【0031】次いで,このプラスミドベクターpUC1
3中の後期蛋白遺伝子領域DNAを既知のプライマーを
用いてPCR法で増幅した(S86)。既知のプライマ
ーには,後期蛋白遺伝子の少なくとも一部がコードされ
ている。次に,増幅した後期蛋白遺伝子領域DNAを,
プラスミドベクターpUC19を用いてサブクローニン
グした(S87)。次に,後期蛋白遺伝子領域DNAを
形質転換法(Hanahan法;Molecular
cloning 2nd ed.,vol.1,198
9)により大腸菌DH5aに導入し,この大腸菌を増殖
させた(S88)。
Then, this plasmid vector pUC1
The late protein gene region DNA in 3 was amplified by PCR using known primers (S86). The known primer encodes at least part of the late protein gene. Next, the amplified late protein gene region DNA is
Subcloning was carried out using the plasmid vector pUC19 (S87). Next, the late protein gene region DNA is transformed by the transformation method (Hanahan method; Molecular).
cloning 2nd ed. , Vol. 1,198
It was introduced into Escherichia coli DH5a according to 9), and this E. coli was grown (S88).

【0032】次いで,図18に示すS91において,増
殖した大腸菌を破壊して,後期蛋白遺伝子領域DNAを
組み込んだプラスミドベクターpUC13を取得した。
次いで,このプラスミドベクターpUC13を制限酵素
EcoRIにより切断して,後期蛋白遺伝子領域DNA
を得た。
Then, in S91 shown in FIG. 18, the proliferated Escherichia coli was destroyed to obtain a plasmid vector pUC13 incorporating the late protein gene region DNA.
Then, the plasmid vector pUC13 was cleaved with the restriction enzyme EcoRI to obtain the late protein gene region DNA.
I got

【0033】(後期蛋白遺伝子領域DNAの切断)次い
で,図18に示すS92において,後期蛋白遺伝子領域
DNAを制限酵素AccIを用いて切断した。これによ
り,216塩基(bp),1065塩基,1035塩
基,及び678塩基の各DNA断片を取得した。これら
の各DNA断片を,それぞれagnoprotein領
域DNA断片,VP1領域DNA断片,VP23領域D
NA断片,及びVP3領域DNA断片と命名した。
(Cleavage of Late Protein Gene Region DNA) Next, in S92 shown in FIG. 18, the late protein gene region DNA was digested with the restriction enzyme AccI. As a result, DNA fragments of 216 bases (bp), 1065 bases, 1035 bases, and 678 bases were obtained. These DNA fragments were respectively labeled as agnoprotein region DNA fragment, VP1 region DNA fragment, and VP23 region D.
They were designated as NA fragment and VP3 region DNA fragment.

【0034】次いで,上記各種DNA断片の位置決定及
び塩基配列調査を行い,その結果を図1〜図4に示し
た。これらの図より,agnoprotein領域DN
A断片は,JCウイルスの複製開始点から下流側(3’
末端側)に数えて第277〜第492番の間に配列する
216個の塩基からなる。
Next, the position of each of the above DNA fragments was determined and the nucleotide sequence was investigated, and the results are shown in FIGS. From these figures, the agnoprotein region DN
The A fragment is located downstream (3 ') from the replication origin of JC virus.
It is composed of 216 bases arranged between the 277th and 492nd positions, counting from the terminal side).

【0035】VP1領域DNA断片は,上記EcoRI
切断部位から下流側に数えて第1469〜第2533番
の間に配列する1065個の塩基からなる。VP23領
域DNA断片は,上記EcoRI切断部位から下流側に
数えて第526〜第1560番の間に配列する1035
個の塩基からなる。
The VP1 region DNA fragment is the above EcoRI.
It is composed of 1065 bases arranged from the 1469th to the 2533rd positions counted from the cleavage site to the downstream side. The VP23 region DNA fragment is counted 1035 downstream from the EcoRI cleavage site and arranged between the 526th to 1560th positions.
It consists of individual bases.

【0036】VP3領域DNA断片は,上記EcoRI
切断部位から下流側に数えて第883〜第1560番の
間に配列する678個の塩基からなる。これらの各種領
域DNA断片の配置関係を,図19に示す。尚,図1〜
図4中,「........」は未明塩基配列を示す。
The VP3 region DNA fragment is the above EcoRI.
It is composed of 678 bases arranged from the 883rd position to the 1560th position downstream from the cleavage site. The positional relationship of these various region DNA fragments is shown in FIG. In addition,
In Fig. 4, "........" indicates an unclear base sequence.

【0037】(agnoprotein領域DNA断片
の増幅)agnoprotein領域DNA断片は,必
要に応じてPCR法により増幅した。
(Amplification of agnoprotein domain DNA fragment) The agnoprotein domain DNA fragment was amplified by PCR if necessary.

【0038】(VP1領域DNA断片の増幅)また,V
P1領域DNA断片を,その5’末端にBamHI認識
配列を,その3’末端にKpnI認識配列を保有したプ
ライマーを用いて,PCR法により増幅した。次いで,
増幅したVP1領域DNA断片を平滑末端とし,プラス
ミドベクターpUC19のHincIII認識部位に挿
入結合し,挿入断片の塩基配列がテンプレートの塩基配
列と相違ないことを確認した。これをpJCTVP1−
pUCという。
(Amplification of VP1 region DNA fragment)
The P1 region DNA fragment was amplified by the PCR method using a primer carrying a BamHI recognition sequence at its 5'end and a KpnI recognition sequence at its 3'end. Then,
The amplified VP1 region DNA fragment was used as a blunt end and inserted and ligated into the HincIII recognition site of the plasmid vector pUC19, and it was confirmed that the base sequence of the inserted fragment was not different from the base sequence of the template. PJCTVP1-
It is called pUC.

【0039】次いで,pJCTVP1−pUCを形質転
換法により大腸菌DH5aに導入し,増殖した。次い
で,大腸菌DH5aの中からpJCTVP1−pUCを
取り出した。次いで,制限酵素を用いてpJCTVP1
−pUCからVP1領域DNA断片を切り出した。
Then, pJCTVP1-pUC was introduced into Escherichia coli DH5a by the transformation method and propagated. Then, pJCTVP1-pUC was taken out from Escherichia coli DH5a. Then, using the restriction enzyme, pJCTVP1
-A VP1 region DNA fragment was excised from pUC.

【0040】(VP23領域DNA断片の増幅)また,
VP23領域DNA断片を,pUC19のAccI/E
coRI切断部位に挿入結合した。これをpJCTVP
23−pUCという。次いで,pJCTVP23−pU
Cを42℃で形質転換法(Hanahan法)により大
腸菌DH5aに導入した。次いで,LB−Agar寒天
培地にIPTG及びX−galを加え,培養した。次い
で,大腸菌DH5aよりpJCTVP23−pUCを取
り出し,精製した。次いで,制限酵素を用いてpJCT
VP23−pUCからVP23領域DNA断片を切り出
した。
(Amplification of VP23 region DNA fragment)
The VP23 region DNA fragment was transferred to AccI / E of pUC19.
It was inserted and ligated into the coRI cleavage site. This is pJCTVP
It is called 23-pUC. Then, pJCTVP23-pU
C was introduced into Escherichia coli DH5a at 42 ° C. by the transformation method (Hanahan method). Then, IPTG and X-gal were added to the LB-Agar agar medium and cultured. Then, pJCTVP23-pUC was taken out from Escherichia coli DH5a and purified. Then, pJCT using restriction enzyme
A VP23 region DNA fragment was excised from VP23-pUC.

【0041】(VP3領域DNA断片の増幅)次いで,
VP3領域DNA断片を,pUC19のAccI/Ec
oRI切断部位に挿入結合した。これをpJCTVP1
−pUCという。次いで,pJCTVP3−pUCを4
2℃で形質転換法(Hanahan法)により大腸菌D
H5aに導入した。次いで,LB−Agar寒天培地に
IPTG及びX−galを加え,培養した。次いで,大
腸菌DH5aよりpJCTVP3−pUCを取り出し,
精製した。次いで,制限酵素を用いてpJCTVP3−
pUCからVP3領域DNA断片を切り出した。
(Amplification of VP3 region DNA fragment)
The VP3 region DNA fragment was transferred to AccI / Ec of pUC19.
It was inserted and linked to the oRI cleavage site. This is pJCTVP1
-It is called pUC. Then, pJCTVP3-pUC is changed to 4
E. coli D by transformation (Hanahan method) at 2 ° C
It was introduced into H5a. Then, IPTG and X-gal were added to the LB-Agar agar medium and cultured. Then, take out pJCTVP3-pUC from E. coli DH5a,
Purified. Then, using the restriction enzyme, pJCTVP3-
A VP3 region DNA fragment was excised from pUC.

【0042】(VP231領域DNA断片の作成)次い
で,図18に示すS93において,VP23領域DNA
断片の3’末端側(下流側)に,VP1領域DNA断片
を連結した。これにより,図19に示すごとく,VP2
31領域DNA断片を得た。
(Preparation of VP231 Region DNA Fragment) Next, in S93 shown in FIG.
The VP1 region DNA fragment was ligated to the 3'end side (downstream side) of the fragment. As a result, as shown in FIG.
A 31-region DNA fragment was obtained.

【0043】(発現ベクターへの組み込み)次いで,図
18に示すS95において,上記各種DNA断片を,動
物細胞発現ベクターのプロモーター下流にリクローニン
グした。動物細胞発現ベクターには,図20に示すごと
く,pcDL─SRa296を用いた。
(Incorporation into Expression Vector) Next, in S95 shown in FIG. 18, the above various DNA fragments were recloned downstream of the promoter of the animal cell expression vector. As the animal cell expression vector, pcDL-SRa296 was used as shown in FIG.

【0044】(宿主細胞への導入)次いで,図18に示
すS96において,上記各種DNA断片を組み込んだ発
現ベクターを,サル腎細胞由来のCOS7細胞に,リポ
フェクチン法を用いて導入した。即ち,上記発現ベクタ
ーとリポフェクトアミン(商品名,Gibco BRL社製)
の複合体を形成させ,これを血清を含有しない培養液
(商品名Opti−MEM,GibcoBRL社製)中
で約4時間かけてCOS7細胞に導入した。その後,上
記培養液を,血清を含む培養液(10%仔ウシ血清含有
Eagles’ minimum essential
medium(MEM),Gibco BRL社製)に交換
して37℃,5%CO2 存在下で72時間培養した。こ
れにより,COS7細胞に上記各種DNA断片由来の蛋
白を発現させた。
(Introduction into Host Cell) Next, in S96 shown in FIG. 18, the expression vector incorporating the above various DNA fragments was introduced into monkey kidney cell-derived COS7 cells by the lipofectin method. That is, the expression vector and lipofectamine (trade name, manufactured by Gibco BRL)
The complex was formed and introduced into COS7 cells in a serum-free culture medium (trade name: Opti-MEM, manufactured by GibcoBRL) for about 4 hours. Then, the above culture solution was added to a culture solution containing serum (Eagles' minimum essential containing 10% calf serum).
The medium was replaced with medium (MEM), manufactured by Gibco BRL) and cultured at 37 ° C. in the presence of 5% CO 2 for 72 hours. As a result, COS7 cells were made to express the proteins derived from the above various DNA fragments.

【0045】次いで,得られた各種蛋白について,蛍光
抗体法及び免疫沈降法により調査した。その結果,VP
1,VP23,VP3領域DNA断片由来の蛋白は,い
ずれもJCウイルス外郭蛋白であった(S97)。VP
1領域DNA断片,VP23領域DNA断片,VP3領
域DNA断片によって得られたJCウイルス外郭蛋白
は,それぞれ外郭の特定部分を構成するという点におい
て差異を有している。
Next, the obtained various proteins were investigated by the fluorescent antibody method and the immunoprecipitation method. As a result, VP
The proteins derived from the 1, VP23 and VP3 region DNA fragments were all JC virus outer coat proteins (S97). VP
The JC virus envelope proteins obtained by the 1-region DNA fragment, the VP23 region DNA fragment, and the VP3 region DNA fragment differ from each other in that they constitute a specific portion of the envelope.

【0046】VP231領域DNA断片由来の蛋白は,
JCウイルス粒子であった(S98)。JCウイルス粒
子は,病原性を有しないため研究に用いる上で安全であ
ること,遺伝子治療における遺伝子導入ベクターとして
使用できる可能性が高いという性質を有する。一方,後
期蛋白遺伝子領域DNAからは,JCウイルス粒子が得
られた。しかし,その産生量は,上記VP231領域D
NA断片からの産生量に比べて著しく少なかった。その
理由は,agnoproteinがJCウイルス粒子の
形成を妨げているためであると考えられる。
The protein derived from the VP231 region DNA fragment is
It was a JC virus particle (S98). JC virus particles have the property that they are safe for use in research because they do not have pathogenicity and that they are highly likely to be used as gene transfer vectors in gene therapy. On the other hand, JC virus particles were obtained from the late protein gene region DNA. However, the production amount is
It was significantly less than the amount produced from the NA fragment. The reason is considered to be that agnoprotein inhibits the formation of JC virus particles.

【0047】次に,上記VP231領域DNA断片由来
のJCウイルス粒子について,電子顕微鏡により観察
し,その写真を図21,図22に示した。これらの写真
より,JCウイルス粒子(点在する黒い粒子)がCOS
7細胞内で産生されていることがわかる。
Next, the JC virus particles derived from the VP231 region DNA fragment were observed by an electron microscope, and the photographs are shown in FIGS. 21 and 22. From these photographs, JC virus particles (black particles scattered) are COS.
It can be seen that it is produced in 7 cells.

【0048】[0048]

【発明の効果】本発明によれば,JCウイルス粒子又は
JCウイルス外郭蛋白を,高い収率で短時間で産生する
ことができる,JCウイルス粒子の製造方法及びJCウ
イルス外郭蛋白の製造方法を提供することができる。
EFFECTS OF THE INVENTION According to the present invention, there are provided a method for producing JC virus particles and a method for producing JC virus envelope proteins, which can produce JC virus particles or JC virus envelope proteins in high yield in a short time. can do.

【図面の簡単な説明】[Brief description of drawings]

【図1】本発明における,JCウイルスの後期蛋白遺伝
子領域DNAの位置,及びその塩基配列を示す説明図
(1)。
FIG. 1 is an explanatory view (1) showing the position of the late protein gene region DNA of JC virus and its nucleotide sequence in the present invention.

【図2】図1に続く,JCウイルスの後期蛋白遺伝子領
域DNAの位置,及びその塩基配列を示す説明図
(2)。
FIG. 2 is an explanatory view (2) showing the position of the late protein gene region DNA of the JC virus and its nucleotide sequence following FIG.

【図3】図2に続く,JCウイルスの後期蛋白遺伝子領
域DNAの位置,及びその塩基配列を示す説明図
(3)。
FIG. 3 is an explanatory view (3) showing the position of the late protein gene region DNA of the JC virus and its nucleotide sequence following FIG. 2.

【図4】図3に続く,JCウイルスの後期蛋白遺伝子領
域DNAの位置,及びその塩基配列を示す説明図
(4)。
FIG. 4 is an explanatory view (4) showing the position of the late protein gene region DNA of the JC virus and its nucleotide sequence following FIG.

【図5】本発明における,JCウイルスのDNAの複製
開始点から下流側に数えて第883番目から第2533
番目までの塩基配列を示す説明図(1)。
FIG. 5 is the 883rd to 2533rd counted from the replication origin of JC virus DNA to the downstream side in the present invention.
Explanatory drawing (1) which shows the base sequence until the 1st.

【図6】図5に続く,JCウイルスのDNAの複製開始
点から下流側に数えて第883番目から第2533番目
までの塩基配列を示す説明図(2)。
FIG. 6 is an explanatory view (2) following FIG. 5, showing the nucleotide sequences from the 883rd position to the 2533rd position counted from the replication origin of JC virus DNA to the downstream side.

【図7】図6に続く,JCウイルスのDNAの複製開始
点から下流側に数えて第883番目から第2533番目
までの塩基配列を示す説明図(3)。
FIG. 7 is an explanatory view (3) following FIG. 6, showing nucleotide sequences from the 883rd position to the 2533rd position counted downstream from the replication origin of JC virus DNA.

【図8】本発明における,agnoprotein領域
DNA断片の塩基配列及びアミノ酸配列を示す説明図。
FIG. 8 is an explanatory view showing the nucleotide sequence and amino acid sequence of an agnoprotein region DNA fragment in the present invention.

【図9】本発明における,VP1領域DNA断片の塩基
配列及びアミノ酸配列を示す説明図(1)。
FIG. 9 is an explanatory diagram (1) showing the nucleotide sequence and amino acid sequence of the VP1 region DNA fragment in the present invention.

【図10】図9に続く,VP1領域DNA断片の塩基配
列及びアミノ酸配列を示す説明図(2)。
FIG. 10 is an explanatory diagram (2) showing the nucleotide sequence and amino acid sequence of the VP1 region DNA fragment following FIG. 9.

【図11】図10に続く,VP1領域DNA断片の塩基
配列及びアミノ酸配列を示す説明図(3)。
FIG. 11 is an explanatory view (3) showing the nucleotide sequence and amino acid sequence of the VP1 region DNA fragment following FIG. 10.

【図12】図11に続く,VP1領域DNA断片の塩基
配列及びアミノ酸配列を示す説明図(4)。
FIG. 12 is an explanatory diagram (4) showing the nucleotide sequence and amino acid sequence of the VP1 region DNA fragment following FIG. 11.

【図13】図12に続く,VP1領域DNA断片の塩基
配列及びアミノ酸配列を示す説明図(5)。
FIG. 13 is an explanatory view (5) showing the nucleotide sequence and amino acid sequence of the VP1 region DNA fragment following FIG. 12.

【図14】本発明における,VP3領域DNA断片の塩
基配列及びアミノ酸配列を示す説明図(1)。
FIG. 14 is an explanatory view (1) showing the nucleotide sequence and amino acid sequence of the VP3 region DNA fragment in the present invention.

【図15】図14に続く,VP3領域DNA断片の塩基
配列及びアミノ酸配列を示す説明図(2)。
FIG. 15 is an explanatory view (2) showing the nucleotide sequence and amino acid sequence of the VP3 region DNA fragment following FIG.

【図16】図15に続く,VP3領域DNA断片の塩基
配列及びアミノ酸配列を示す説明図(3)。
FIG. 16 is an explanatory view (3) showing the base sequence and amino acid sequence of the VP3 region DNA fragment following FIG. 15.

【図17】実施形態例における,JCウイルス粒子及び
JCウイルス外郭蛋白を製造する方法を示す説明図。
FIG. 17 is an explanatory view showing a method for producing JC virus particles and JC virus outer coat protein in the embodiment.

【図18】図17に続く,JCウイルス粒子及びJCウ
イルス外郭蛋白の製造方法を示す説明図。
FIG. 18 is an explanatory view showing a method for producing JC virus particles and JC virus outer coat protein, following FIG. 17.

【図19】実施形態例における,発現ベクターに組み込
む各種DNA断片の説明図。
FIG. 19 is an explanatory diagram of various DNA fragments incorporated into an expression vector in the embodiment.

【図20】実施形態例における,発現ベクター(pcD
L−SRα296)の説明図。
FIG. 20 shows the expression vector (pcD in the embodiment).
Explanatory drawing of L-SR (alpha) 296.

【図21】実施形態例において,COS7細胞内で産生
したJCウイルス粒子の電子顕微鏡写真(倍率1000
0倍)により示した図面代用写真。
FIG. 21 is an electron micrograph of JC virus particles produced in COS7 cells in an example embodiment (magnification: 1000).
(0x) The drawing substitute photograph shown by.

【図22】実施形態例において,COS7細胞内で産生
したJCウイルス粒子の電子顕微鏡写真(倍率5000
0倍)により示した図面代用写真。
FIG. 22 is an electron micrograph of JC virus particles produced in COS7 cells in an example embodiment (magnification: 5000).
(0x) The drawing substitute photograph shown by.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 //(C12P 21/02 C12R 1:91) (72)発明者 宍戸 由紀子 北海道札幌市北区北15条西7丁目 北海道 大学病理第2講座内 (72)発明者 鍵山 直人 愛知県刈谷市朝日町2丁目1番地 アイシ ン精機株式会社内─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification number Reference number within the agency FI technical display part // (C12P 21/02 C12R 1:91) (72) Inventor Yukiko Shishido Kita-ku, Sapporo-shi, Hokkaido Article 15 West 7-chome, Hokkaido University, Second Department of Pathology (72) Inventor Naoto Kagiyama 2-chome, Asahi-cho, Kariya city, Aichi Aisin Seiki Co., Ltd.

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】 下記の「図1」〜「図4」に示すJCウ
イルスの後期蛋白遺伝子領域を含むDNA断片を調製
し,次いで,上記DNA断片から,上記後期蛋白遺伝子
領域の内,複製開始点から下流側に数えて第277〜第
492番の間に配列したagnoprotein領域を
欠失させて,ウイルス粒子産生性DNA断片を調製し,
次いで,上記ウイルス粒子産生性DNA断片を発現ベク
ターに組み込み,次いで,該発現ベクターを宿主細胞に
導入してJCウイルス粒子を産生させることを特徴とす
るJCウイルス粒子の製造方法。 【図1】 【図2】 【図3】 【図4】
1. A DNA fragment containing the late protein gene region of JC virus as shown in the following "FIG. 1" to "FIG. 4" is prepared, and then replication is initiated from the above DNA fragment in the late protein gene region. The viral particle-producing DNA fragment is prepared by deleting the agnoprotein region arranged between the 277th and 492nd positions counting from the point to the downstream side,
Next, a method for producing JC virus particles, which comprises incorporating the above virus particle-producing DNA fragment into an expression vector, and then introducing the expression vector into a host cell to produce JC virus particles. [FIG. 1] [FIG. 2] [FIG. 3]
【請求項2】 請求項1において,上記後期蛋白遺伝子
領域を含むDNA断片は,複製開始点から下流側に数え
て第883〜第2533番の間に存在する塩基配列が,
下記の「図5」〜「図7」に示す塩基配列からなること
を特徴とするJCウイルス粒子の製造方法。 【図5】 【図6】 【図7】
2. The DNA fragment containing the late protein gene region according to claim 1, wherein the nucleotide sequence existing between the 883rd and the 2533rd positions counted downstream from the replication origin is:
A method for producing a JC virus particle, which comprises the base sequence shown in the following "Fig. 5" to "Fig. 7". 5] FIG. 6]
【請求項3】 請求項1又は2において,上記ウイルス
粒子産生性DNA断片は,複製開始点から下流側に数え
て第526〜第2533番の間に配列するVP231領
域を含むことを特徴とするJCウイルス粒子の製造方
法。
3. The viral particle producing DNA fragment according to claim 1 or 2, wherein the viral particle-producing DNA fragment includes a VP231 region arranged between the 526th and the 2533rd counting from the replication origin to the downstream side. Method for producing JC virus particles.
【請求項4】 下記の「図1」〜「図4」に示すJCウ
イルスの後期蛋白遺伝子領域を含むDNA断片を調製
し,次いで,上記後期蛋白遺伝子領域の内,複製開始点
から下流側に数えて第526〜第1560番の間に配列
するVP23領域を含むVP23領域DNA断片と,複
製開始点から下流側に数えて第1469〜第2533番
の間に配列するVP1を含むVP1領域DNA断片と,
複製開始点から下流側に数えて第883〜第1560番
の間に配列するVP3領域を含むVP3領域DNA断片
とを調製し,次いで,上記VP23領域DNA断片と上
記VP1領域DNA断片と上記VP3領域DNA断片と
をそれぞれ発現ベクターに組み込み,次いで,上記VP
23領域DNA断片を組み込んだ発現ベクターと,上記
VP1領域DNA断片を組み込んだ発現ベクターと,上
記VP3領域DNA断片を組み込んだ発現ベクターと
を,宿主細胞に導入してJCウイルス外郭蛋白を産生さ
せることを特徴とするJCウイルス外郭蛋白の製造方
法。 【図1】 【図2】 【図3】 【図4】
4. A DNA fragment containing the late protein gene region of JC virus as shown in the following "FIG. 1" to "FIG. 4" is prepared, and then, in the late protein gene region, from the replication origin to the downstream side. A VP23 region DNA fragment containing the VP23 region arranged between the 526th and 1560th counts and a VP1 region DNA fragment containing the VP1 arranged between the 1469th and 2533rd counts downstream from the replication origin When,
A VP3 region DNA fragment containing the VP3 region arranged between the 883rd to 1560th positions counted downstream from the replication origin is prepared, and then the VP23 region DNA fragment, the VP1 region DNA fragment, and the VP3 region are prepared. The DNA fragment and the VP are respectively incorporated into an expression vector, and then the VP
An expression vector incorporating a 23-region DNA fragment, an expression vector incorporating the VP1 region DNA fragment, and an expression vector incorporating the VP3 region DNA fragment are introduced into a host cell to produce a JC virus envelope protein. A method for producing a JC virus outer shell protein, comprising: [FIG. 1] [FIG. 2] [FIG. 3]
JP8062167A 1996-02-23 1996-02-23 Production of both jc virus particle and coat protein of jc virus Pending JPH09224658A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8062167A JPH09224658A (en) 1996-02-23 1996-02-23 Production of both jc virus particle and coat protein of jc virus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8062167A JPH09224658A (en) 1996-02-23 1996-02-23 Production of both jc virus particle and coat protein of jc virus

Publications (1)

Publication Number Publication Date
JPH09224658A true JPH09224658A (en) 1997-09-02

Family

ID=13192307

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8062167A Pending JPH09224658A (en) 1996-02-23 1996-02-23 Production of both jc virus particle and coat protein of jc virus

Country Status (1)

Country Link
JP (1) JPH09224658A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003044184A1 (en) * 2001-11-22 2003-05-30 Japan Science And Technology Agency Treatment of pml targeting jc virus agno

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003044184A1 (en) * 2001-11-22 2003-05-30 Japan Science And Technology Agency Treatment of pml targeting jc virus agno

Similar Documents

Publication Publication Date Title
Leder et al. Enhancement of capsid gene expression: preparing the human papillomavirus type 16 major structural gene L1 for DNA vaccination purposes
JP4546092B2 (en) vaccine
KR20200003390A (en) Alpha virus neoantigen vector
EP3670650B1 (en) Cell strain for reducing production of reproducible adenovirus, and construction method and use
Li et al. Importance of Vp1 calcium-binding residues in assembly, cell entry, and nuclear entry of simian virus 40
JPS6356292A (en) Production of recombinant dna molecule
EP0038765A1 (en) Vaccine against viral hepatitis B, method and transformed eucaryotic cells for the preparation of this vaccine
TW201945388A (en) Optimized engineered meganucleases having specificity for a recognition sequence in the hepatitis B virus genome
KR20220016137A (en) modified adenovirus
CN111218477B (en) Avian type 4 adenovirus vector for targeted infection of mammalian cells and application thereof
WO2017128783A1 (en) Ebola virus disease vaccine taking human replication deficient adenovirus as vector
Valley-Omar et al. Abrogation of contaminating RNA activity in HIV-1 Gag VLPs
Tenen et al. Biological and biochemical studies of cells transformed by simian virus 40 temperature-sensitive gene A mutants and A mutant revertants
JPS58500167A (en) Selective genetic markers for eukaryotic cells, methods of using such markers and their application in the production of specific proteins after transformation of cells containing such markers with the corresponding DNA.
JPH0314840B2 (en)
CN107667175A (en) Vaccine based on restructuring mumps virus JERYL LYNN 2
CN110951778B (en) CDV-3 strain infectious cDNA clone of canine distemper virus, construction method and application thereof
JPH04504357A (en) Vaccinia vector, vaccinia gene and its expression product
JP2022541464A (en) Oncolytic viruses, their uses, and medicines to treat cancer
CN115678906B (en) Optimized novel coronavirus chimeric nucleic acid vaccine and uses thereof
JPH09224658A (en) Production of both jc virus particle and coat protein of jc virus
JP2004175665A (en) Protein hollow nanoparticle and drug using the same
Pantelic et al. Cryoelectron microscopy map of Atadenovirus reveals cross-genus structural differences from human adenovirus
CN110893240B (en) Application of NME2 gene in inhibiting avian reovirus replication
JPH01218590A (en) Rinderpest virus vaccine using recombinant vaccinia virus